Fig. 3From: An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospitalColistin, piperacillin-tazobactam, and meropenem consumption (defined daily dose/100 bed days) before and after intervention in the intensive care unit (left panel) and in the medical and surgical departments (right panel). *p < 0.05 for comparison with preintervention periodBack to article page